Coagulation Factors in Mexican Children, Young Adults and Older Adults

Jessica Viviana Nieves-Hernández1, Edgar Hernández-Zamora2, Marlene Galicia-Alvarado3

  • 1Morphology Department, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional (ENCB, IPN), Mexico City, Mexico.

Insights

Coagulation factor levels in Mexican adults vary significantly by age, with factors V and XII potentially serving as aging biomarkers. These findings necessitate updated diagnostic reference values for accurate bleeding disorder diagnosis.

Area of Science:

  • Clinical Chemistry
  • Hematology
  • Gerontology

Background:

  • Accurate diagnosis of bleeding disorders relies on clinical chemistry laboratory tests.
  • Limited data exists on reference values for coagulation factors in Mexico.
  • Previous studies focused on adults and older adults, leaving pediatric and young adult ranges undefined.

Purpose of the Study:

  • To determine coagulation factor levels in healthy Mexican minors, young adults, and older adults.
  • To investigate age-related differences in coagulation factor activity.
  • To establish age-specific reference values for coagulation factors in Mexico.

Main Methods:

  • Coagulation analyzer with commercial kits used to measure coagulation factors I, II, V, VII, VIII, IX, X, XI, and XII.
  • Statistical analysis included Kruskal-Wallis tests, Dunn-Bonferroni post hoc tests, and effect size calculations (Glass's rank biserial correlation, epsilon-squared).
  • 347 participants were stratified by age group (minors, young adults, older adults) and sex.

Main Results:

  • Significant variability in coagulation factor activity was observed across age groups.
  • Age was a significant factor influencing the activity of all tested coagulation factors.
  • Factors V and XII showed notable age-related changes, suggesting their potential as biomarkers of aging.

Conclusions:

  • Coagulation factor levels in older adults differ from those in younger age groups and established commercial kit reference values.
  • These findings underscore the need for age-specific reference values in Mexico.
  • Integration into diagnostic algorithms and clinical guidelines is crucial for accurate hemostatic disorder diagnosis.

Related Concept Videos

Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
11.9K
Coagulation01:06

Coagulation

Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.6K
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
15.6K
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
6.7K